z-logo
Premium
A 24‐week pegylated interferon alpha‐2b versus a 12‐week pegylated interferon alpha‐2b alone or with ribavirin for patients with acute hepatitis C
Author(s) -
Dai ChiaYen,
Chuang WanLong,
Yu MingLung
Publication year - 2014
Publication title -
hepatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.488
H-Index - 361
eISSN - 1527-3350
pISSN - 0270-9139
DOI - 10.1002/hep.27096
Subject(s) - ribavirin , medicine , pegylated interferon , alpha interferon , alpha (finance) , hepatitis c , gastroenterology , pharmacology , interferon , chronic hepatitis , virology , surgery , virus , construct validity , patient satisfaction

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom